Cost-effectiveness analysis in clinical practice: the case of heart failure.
about
The use of economic evaluation in CAM: an introductory framework.Outpatient management of heart failure in the United States, 2006-2008.Heart failure in the 21st century: a cardiogeriatric syndrome.Nitroxyl gets to the heart of the matter.Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban communityNesiritide: a novel approach for acute heart failure.Heart failure disease management: impact on hospital care, length of stay, and reimbursement.Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia.Alterations in energy metabolism in cardiomyopathies.Symptom distress and quality of life in patients with advanced congestive heart failure.Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples.Novel interactive cell-phone technology for health enhancement.Cost analysis of the Geriatric Resources for Assessment and Care of Elders care management interventionSelf-Reported Masticatory Dysfunction and Mortality in Community Dwelling Elderly Adults: A 9-Year Follow-Up.The Performance of Short-Term Heart Rate Variability in the Detection of Congestive Heart FailureUse of calcium antagonists and worsening renal function in patients receiving angiotensin-converting-enzyme inhibitors.Depressive symptoms are associated with hospitalization, but not with mortality in the elderly: a population-based study.N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction.Metabolic syndrome and quality of life in the elderly: age and gender differences.
P2860
Q33743692-E9790565-EEF6-43AC-9EB1-EA6A1186561EQ33766193-E6C03410-B180-4606-9A9E-76CC8B17DB72Q34159039-A71F9882-F028-4F37-8E2B-00ADF7D7DFE4Q34981557-BBBD7AB2-4C6E-4EC5-A50D-177A743D37A7Q35031948-1C5B2C05-E26A-4B32-AD77-6E27FFAF8D3EQ35054263-A2A28123-6604-4775-B4C8-BDD00BCCBD7CQ35097107-460C1BD4-0AE6-4822-8F4D-07CEA4AC7C7CQ35567128-C8278B1E-2C1C-4B24-A122-68F213C86000Q36124913-F3E33EED-D559-40B8-BCCD-F4F8EAF8BF2DQ36220123-6F989347-89B8-44D6-B8F3-0F0357834F8AQ36970329-A8C41D5A-74FE-4D29-B292-FB488A159A6AQ37143140-C6CAC34E-35A7-4635-8A10-FCA357B97DE8Q37167529-90ABE1BD-B8BE-4862-B464-F26A90547B44Q37404106-D5D920D7-0FF1-4EE0-A3B2-AF4BA014C51AQ37417974-C91AC69E-E358-44A7-9788-8B12BEF0B14DQ40455947-0D441C7A-E3D6-471F-8018-6A045E7A9783Q42178064-6662046C-C64B-4A24-8291-455F5620B622Q44334649-E630DB50-DA0C-4C6F-920B-8A8F2D33B5F0Q46714757-EB7395A8-EFF2-4EBF-8D43-C6210BBAE205Q48030167-9932579F-7F47-4940-8891-63CCA153CAA8Q48469995-C02C87B2-B092-49B7-9346-893FDBC22C51
P2860
Cost-effectiveness analysis in clinical practice: the case of heart failure.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@ast
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@en
type
label
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@ast
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@en
prefLabel
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@ast
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@en
P1476
Cost-effectiveness analysis in clinical practice: the case of heart failure.
@en
P2093
P304
P356
10.1001/ARCHINTE.159.15.1690
P407
P577
1999-08-01T00:00:00Z